-
Democrats, Trump hold final rallies before midterm elections
-
African players in Europe: Defender Hakimi's historic hat-trick
-
Japan urges US to enforce discipline after second Marine arrest
-
Struggling Slavia face Arsenal as grim record looms
-
'Remarkable' rookie Lendeborg scores 37 as Warriors beat Clippers
-
Vikings suffer first loss while Broncos edge Chiefs in NFL
-
ExxonMobil urged to re-think Papua New Guinea gas project
-
South Korea to double spending on AI and chips in 2027
-
Asian stocks mixed as tech sector struggles to rebound from selloff
-
On All Saints' Day, Philippine mountain town honours dead with fire
-
India's royals find new power in their past
-
Years on from fall of IS, French jihadists face justice in Iraq
-
Irish bookshops help meet UK demand for Sally Rooney novels
-
Point of Law favourite at Australia's 'race that stops a nation'
-
NFL Vikings suffer first loss while Broncos edge Chiefs
-
'Kid' Antonelli gets affectionate tributes from all quarters
-
Host of fresh faces in Australia white-ball squads to face England
-
Hamilton accuses Leclerc of wrecking Ferrari hopes
-
NFL linebacker Campbell to remain hospitalized overnight
-
enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
-
Gladstone Alternative Income Fund Announces Monthly Cash Distribution for November 2026
-
Nexscient Announces Expanded Customer Engagements and New Commercial Agreements in Autonomous Driving and Humanoid Robotics Data Services
-
Vicapsys Life Sciences Provides Shareholder Update on VICAPSYN(TM) Program Advancing Toward Phase 1 Human Clinical Trial, Vertically Integrated With the Company's Indian Health Service Strategy
-
XCF Global Withdraws Reverse Stock Split Proposal; Reaffirms Growth Strategy and Shareholder Support
-
Gladstone Commercial Corporation Earnings Call and Webcast Information
-
cbdMD Completes Acquisition of the Operating Assets and Brands of Twinlab, including Twinlab, Reserveage and Metabolife Brands, Expanding Into Broader Wellness
-
Palo Alto Collaboration Company Opens Waitlist for Pana, a Personal AI That Builds Tools That Stay Yours
-
Anthony, Linder & Cacomanolis Recognized in Chambers & Partners Spotlight Florida 2027 for Securities Law Excellence
-
Tectonic Metals Intersects 5.61 g/t Au Over 41.15 m, Including 12.94 g/t Au Over 13.72 m, Within 2.86 g/t Au Over 91.44 m, Strengthening Evidence for a Second Gold System at the Flat Gold Project
-
IRS Pushes Tax Deadlines to February 1, 2027 for Washington Wildfire Counties - Clear Start Tax Explains What the Postponement Does Not Pause
-
Optimistivity Unveils Refreshed Brand and Expanded Digital Product Range
-
GameSquare to Report Q3 2026 Financial Results on November 16, 2026
-
AsiaFIN Holdings Corp. to Host Q3 2026 Earnings Webcast from New York City
-
Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
-
Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
-
iAsk.ai Surpasses One Billion Searches
-
International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
-
Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
-
BEING rather than HAVING. A fascinating, practical STORY.
-
Hospital AI Funding Faces a Reality Check: New 2027 Outlook Puts Outsourcing Savings to the Test
-
Jaguar Mining Provides Update on Permitting of the Onças de Pitangui Development Project, Minas Gerais, Brazil
-
Ur-Energy Announces Retirement of CFO Roger Smith, Names VP Finance Jade Walle as Successor
-
DataMEDS AI Enters Into Agreement for Commercial Supply of Six Peptides Recommended by FDA Advisory Committee
-
Aer Lingus and MTech Mobility Launch Live Ground Operations Technology Programme Across Three Irish Airports
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 02
-
Medical Care Technologies Inc. (OTCID:MDCE) Delivers Stronger Melanoma Scan Beta Readout on Expanded Human-Submitted Dataset
-
With Expansion into Naval Shipbuilding, Hanwha Philly Shipyard Names 25-Year Shipbuilding Veteran as President
-
ASGA's Attack on Menhaden Science Exposes Its Own Double Standard
-
Family Hospice Care Celebrates 20 Years of Light, Love and Legacy During National Home Health Month and Hospice and Palliative Care Month
-
Hop-on (OTCID: HPNN) Subsidiary Digitalage Completes Core Cre-ator Platform Build, Moves to Enterprise Technology Licensing
InTheZone Labs Gains Momentum on TikTok as Customers Highlight Unexpected De-Aging Benefits
A wholly owned subsidiary of Nitches Inc. (OTC:NICH), InTheZone Labs is at the forefront of a rising health movement as customers uncover powerful De-Aging effects from its premium nootropic formulations.
MIAMI, FL / ACCESS Newswire / February 7, 2025 / Nitches Inc, (OTC PINK:NICH) InTheZone Labs, a leading innovator in cognitive and performance-enhancing supplements, is rapidly gaining attention on TikTok and social media as customers share remarkable results from using the brand's products. While originally developed for focus, memory, and cognitive clarity, a growing number of users have reported unexpected De-Aging benefits-a concept that could redefine the longevity and wellness industry.
The viral response on TikTok is not surprising, as the platform thrives on real user experiences and rapid trends. People don't just talk about products-they showcase their transformations. And as users began sharing their increased energy, clearer more sharp and focused mind, improved cognitive performance, and youthful vitality, one theme kept emerging: Could InTheZone Labs be a hidden gem in the emerging trillion-dollar De-Aging industry?
The Rise of De-Aging: A Trillion-Dollar Opportunity
De-Aging is not just skincare or anti-wrinkle creams-it's a scientific movement focused on reversing biological aging at the cellular level. This growing industry is fueled by breakthroughs in nootropics, bioceuticals, and regenerative medicine, attracting elite biohackers, longevity researchers, and high-performing individuals looking for an edge in both lifespan and healthspan. Most do not realize that you have to heal from the inside as well as the outside.
According to market research, the anti-aging and longevity industry is projected to surpass $1 trillion by 2030, with growing consumer demand for solutions that enhance not only how long we live, but how well we live.
And that's where InTheZone Labs enters the conversation.
Key De-Aging Ingredients in InTheZone Labs Products
Customers have unknowingly been biohacking their longevity while using InTheZone Labs' supplements for focus and performance. Many of the brand's clinically backed ingredients align directly with De-Aging research and cellular rejuvenation.
Resveratrol (InTheZone Youth) - A potent antioxidant that activates sirtuins, known as the body's "longevity genes," helping to slow biological aging and improve mitochondrial function.
Collagen & Hyaluronic Acid (InTheZone Youth) - Essential for skin elasticity, joint health, and tissue repair, promoting a more youthful appearance and enhanced recovery.
Omega-3 DHA (InTheZone Youth) - Critical for brain longevity, cognitive function, and reducing inflammation, a key factor in aging-related decline.
Alpha-GPC & Bacopa Monnieri (InTheZone Focused Extreme) - Supports neuroplasticity, memory retention, and brain function, helping to keep the mind sharp as we age.
L-Theanine & L-Tyrosine (InTheZone Focused Extreme) - Reduces stress while enhancing cognitive performance, keeping the brain in peak condition.
This fusion of neuroscience-backed performance and longevity-enhancing compounds positions InTheZone Labs as a pioneer in the future of De-Aging supplements.
Expanding Distribution: The Opportunity for Affiliates & Retailers
As the buzz continues to build, InTheZone Labs is looking to expand its distribution network, creating exclusive opportunities for affiliates, distributors, and store representatives to capitalize on this viral movement.
Retailers and health-focused businesses who partner with InTheZone Labs will be at the forefront of one of the most explosive health trends of the decade. As De-Aging awareness grows, early collaborators will solidify their position in a booming industry that blends cognitive enhancement with longevity science.
Interested in partnering? Join the InTheZone Labs affiliate and distributor program today:
ShareASale: Sign Up Here
Direct via InTheZone Labs: Apply Here
Final Thoughts
The future of longevity, performance, and cognitive health is here. InTheZone Labs didn't set out to create a De-Aging product-but the results speak for themselves. As more users discover these benefits, the company is embracing the future of health optimization and leading the charge into the next evolution of human potential.
For media inquiries, partnerships, or more information, visit InTheZoneLabs.com
Follow the conversation on TikTok and see the movement unfold in real-time.
https://tiktok.com/@inthezonelabs
Get InTheZone Labs products on Amazon as well.
https://www.amazon.com/InTheZone-Focused-Extreme-Nutraceutical-Bioceutical-Grade/dp/B0DPVRQ8XC/ref=sr_1_2?dib=eyJ2IjoiMSJ9.qODSSWBzQIkdROjLQfnQ1Y7yw13qlBJksCCYDsW9pGk.PumZWp7-WcmMFS99pniVJdXndYkKT9WDAc1Sto6y0-s&dib_tag=se&keywords=InTheZone+Labs&qid=1738899128&sr=8-2
#DeAgingRevolution #StayInTheZone #FutureOfLongevity
About InTheZone Labs
InTheZone Labs, a wholly owned subsidiary of Nitches Inc. (OTC PINK:NICH), is a premium supplement brand dedicated to enhancing focus, performance, and longevity. By leveraging scientifically-backed nootropics and bioceuticals, InTheZone Labs delivers cutting-edge formulations designed to help individuals stay sharp, energized, and in control of their future.
FDA Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before starting any dietary supplement, especially if you are pregnant, nursing, taking medication, or have a medical condition.
Forward-Looking Statements:
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on current expectations, estimates, and projections about Nitches Corp's industry, management's beliefs, and certain assumptions made by management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to certain risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual results may differ materially from what is expressed or forecasted in such forward-looking statements. Except as required by law, Nitches Corp undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact Information
John Morgan
Ceo
[email protected]
SOURCE: Nitches, Inc.
View the original press release on ACCESS Newswire
R.Garcia--AT